. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Controlled Clinical Trials as TopicDrug InteractionsEpoprostenol/adverse effectsEpoprostenol/analogs & derivativesEpoprostenol/pharmacologyEpoprostenol/therapeutic useHumansHypertension, Pulmonary/drug therapyInjections, SubcutaneousMyocardial ContractionPlatelet Aggregation/drug effectsVasodilator Agents/adverse effectsVasodilator Agents/pharmacologyVasodilator Agents/therapeutic use
Substances: See more » Vasodilator AgentsEpoprostenoltreprostinil
Year: 2002 PMID: 12237619
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909